Gauging heterogeneity in primary versus recurrent glioblastoma
- PMID: 25972456
- PMCID: PMC5762011
- DOI: 10.1093/neuonc/nov078
Gauging heterogeneity in primary versus recurrent glioblastoma
Figures
Comment on
-
Changes in the EGFR amplification and EGFRvIII expression between paired primary and recurrent glioblastomas.Neuro Oncol. 2015 Jul;17(7):935-41. doi: 10.1093/neuonc/nov013. Epub 2015 Feb 16. Neuro Oncol. 2015. PMID: 25691693 Free PMC article.
References
-
- Phillips HS, Kharbanda S, Chen R, et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell. 2006;9(3):157–173. - PubMed
-
- Gravendeel LA, Kouwenhoven MC, Gevaert O, et al. Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology. Cancer Res. 2009;69(23):9065–9072. - PubMed
-
- Sturm D, Witt H, Hovestadt V, et al. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell. 2012;22(4):425–437. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
